Status:
COMPLETED
Non-Interventional Study With Aricept® Evess
Lead Sponsor:
Pfizer
Conditions:
Alzheimer's Disease
Vascular Dementia
Eligibility:
All Genders
50+ years
Brief Summary
The Aricept® Evess study is a prospective, non-comparative, non-interventional study on use of Aricept® Evess in the treatment of out-patients with AD and Vascular Dementia. The 24 week length of the ...
Eligibility Criteria
Inclusion
- Outpatients (male / female), older than 50 years.
- Patients with clinical symptoms of mild and moderate AD and Vascular Dementia.
- MMSE score between 12 - 24.
Exclusion
- Patients with a known hypersensitivity to donepezil clorhydrat, piperidine derivatives or any of the excipients of Aricept® Evess.
- Patients with severe impaired hepatic function.
- Patients with pre-existing gastrointestinal ulcer disease.
- Patients with the history of bronchial asthma or chronic obstructive lung disease.
- Patients with the history of serious atrioventricular conduction disturbances.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT00889603
Start Date
May 1 2009
End Date
March 1 2010
Last Update
March 31 2011
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bacau, Jud. Bacau, Romania, 600114
2
Pfizer Investigational Site
Cluj-Napoca, Jud. Cluj, Romania, 400001
3
Pfizer Investigational Site
Cluj-Napoca, Jud. Cluj, Romania
4
Pfizer Investigational Site
Constanța, Jud. Constanta, Romania